| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunome, Inc. (IMNM) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 2 sells. IMNM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 360.0K | $9.30M | - | |
| Dir | 341.1K | $8.81M | - | |
| Dir | 108.5K | $2.80M | - | |
| CFO | 94.5K | $2.44M | - | |
| Other | 76.5K | $1.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | Tsai Philip76 | Chief Technology Officer | Buy | 21,000 | $9.43 | $198,030.00 | New | +5.1% | +96.7% | |
| Sep 19, 2024 | Rosett Max | Chief Financial Officer | Sale+OE | 14,380 | $16.01 | $230,223.80 | -23.2% | -27.3% | -38.6% | |
| Aug 16, 2024 | Bienaime Jean Jacques68 | Director | Buy | 7,000 | $13.94 | $97,608.00 | +72.8% | -17.7% | -24.0% | |
| Aug 15, 2024 | Higgins Jack | Chief Scientific Officer | Sale+OE | 3,524 | $13.93 | $49,071.70 | -18.0% | -16.9% | -26.3% | |
| May 21, 2024 | Bienaime Jean Jacques68 | Director | Buy | 2,000 | $13.57 | $27,139.80 | +26.3% | +4.8% | -42.0% | |
| May 21, 2024 | Siegall Clay B77 | President And CEO | Buy | 100,000 | $13.88 | $1,388,072.19 | +13.9% | +4.8% | -42.0% | |
| Oct 2, 2023 | Siegall Clay B77 | President And CEO | Buy | 169,204 | $5.91 | $999,995.64 | +112.5% | +34.3% | +64.9% | |
| Oct 2, 2023 | Turner Bruce | Chief Strategy Officer | Buy | 42,300 | $5.91 | $249,993.00 | New | +34.3% | +64.9% | |
| Sep 13, 2021 | Rapp Michael | Director | Buy | 25,962 | $19.96 | $518,201.52 | +14.2% | -19.6% | -76.0% | |
| Sep 10, 2021 | Rapp Michael | Director | Buy | 45,950 | $18.07 | $830,448.60 | +10.2% | -9.1% | -71.3% |